{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:41:57Z","timestamp":1790422917543,"version":"4.1.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vasc Med"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Effective and durable options for infrapopliteal artery revascularization for patients with chronic limb-threatening ischemia (CLTI) are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The SAVAL trial is a prospective, multicenter, randomized trial of patients with CLTI and infrapopliteal artery lesions with total lesion length \u2a7d 140 mm, stenosis \u2a7e 70%, and Rutherford category 4\u20135 assigned 2:1 to treatment with the SAVAL self-expandable paclitaxel drug-eluting stent (DES) or percutaneous transluminal angioplasty (PTA) with an uncoated balloon. The primary effectiveness endpoint was primary vessel patency (i.e., core lab-adjudicated duplex ultrasound-based flow at 12 months in the absence of clinically driven target lesion revascularization or surgical bypass of the target lesion). The primary safety endpoint was the 12-month major adverse event (MAE)-free rate; MAEs were defined as a composite of above-ankle index limb amputation, major reintervention, and 30-day mortality. The endpoints were prespecified for superiority (effectiveness) and noninferiority (safety) at a one-sided significance level of 2.5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 201 patients were enrolled and randomly assigned to treatment ( N = 130 DES, N = 71 PTA). Target lesion length was 68.1 \u00b1 35.2 mm for the DES group and 68.7 \u00b1 49.2 mm for the PTA group, and 31.0% and 27.6% of patients, respectively, had occlusions. The 12-month primary patency rates were 68.0% for the DES group and 76.0% for the PTA group (P\n                      <jats:sub>superiority<\/jats:sub>\n                      = 0.8552). The MAE-free rates were 91.6% and 95.3%, respectively (P\n                      <jats:sub>noninferiority<\/jats:sub>\n                      = 0.0433).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The SAVAL trial did not show benefit related to effectiveness and safety with the nitinol DES compared with PTA in infrapopliteal artery lesions up to 140 mm in length. Continued innovation to provide optimal treatments for CLTI is needed. (ClinicalTrials.gov Identifier: NCT03551496)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1358863x231199489","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T13:52:26Z","timestamp":1697464346000},"page":"571-580","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":33,"title":["Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries"],"prefix":"10.1177","volume":"28","author":[{"given":"Hans","family":"van Overhagen","sequence":"first","affiliation":[{"name":"Haga Teaching Hospital, Den Haag, South Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Toho University Ohashi Medical Center, Meguro, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J","family":"Geraghty","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, St Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid","family":"Rao","sequence":"additional","affiliation":[{"name":"Vascular Solutions of North Carolina, Cary, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Arroyo","sequence":"additional","affiliation":[{"name":"St Bernard\u2019s Heart and Vascular, Jonesboro, AR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-7304","authenticated-orcid":false,"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital, Hyogo, Amagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-8363","authenticated-orcid":false,"given":"Ehrin","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO, USA"},{"name":"Adventist Heart and Vascular Institute, Adventist Health, St Helena, CA, USA (current)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[{"name":"Tokyo Bay Medical Center, Urayasu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Kishiwada Tokushukai Hospital, Osaka, Osaka Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M","family":"Ansari","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh J","family":"Mathews","sequence":"additional","affiliation":[{"name":"Bradenton Cardiology Center, Manatee Memorial Hospital, Bradenton, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Gou\u00ebffic","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Paris Saint Joseph, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Jaff","sequence":"additional","affiliation":[{"name":"Boston Scientific, Marlborough, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Weinberg","sequence":"additional","affiliation":[{"name":"VasCore \u2013 The Vascular Imaging Core Laboratory, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane S","family":"Pinto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ohura","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Mitaka, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Couch","sequence":"additional","affiliation":[{"name":"George Washington University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-8080","authenticated-orcid":false,"given":"Jihad A","family":"Mustapha","sequence":"additional","affiliation":[{"name":"Michigan State University College of Human Medicine, East Lansing, MI, USA"},{"name":"Advanced Cardiac and Vascular Centers for Amputation Prevention, Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"bibr1-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2019.05.006"},{"key":"bibr2-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-020-02602-6"},{"key":"bibr3-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.04.057"},{"key":"bibr4-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.01.019"},{"key":"bibr5-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.06.1198"},{"key":"bibr6-1358863X231199489","unstructured":"Premarket Approval Application (PMA) for the Lutonix 014 Drug Coated Balloon (Lutonix 014 DCB) Cardiovascular Devices Advisory Panel Meeting, February 17, 2021, https:\/\/www.fda.gov\/media\/146130\/download (2021, accessed 12 November 2022)."},{"key":"bibr7-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021204294"},{"key":"bibr8-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr144"},{"key":"bibr9-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.07.099"},{"key":"bibr10-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.989"},{"key":"bibr11-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376"},{"key":"bibr12-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1177\/1526602816671740"},{"key":"bibr13-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332"},{"key":"bibr14-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2001.112326"},{"key":"bibr15-1358863X231199489","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide, https:\/\/euroqol.org\/publications\/user-guides\/ (2019, accessed 21 September 2023)."},{"key":"bibr16-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2013.10.012"},{"key":"bibr17-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12395"},{"key":"bibr18-1358863X231199489","unstructured":"US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), et al. Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency: Guidance for Industry, Investigators, and Institutional Review Boards, https:\/\/www.fda.gov\/media\/136238\/download (2020, updated 2021, accessed 9 Dec-ember 2021)."},{"key":"bibr19-1358863X231199489","first-page":"207","volume":"55","author":"Fanelli F","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"bibr20-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.4103\/jcis.JCIS_34_17"},{"key":"bibr21-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001811"},{"key":"bibr22-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.07.011"},{"key":"bibr23-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1615\/JLongTermEffMedImplants.v10.i12.120"},{"key":"bibr24-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.23.2816"},{"key":"bibr25-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.10.061"},{"key":"bibr26-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109305"},{"key":"bibr27-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1380"},{"key":"bibr28-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004877"},{"key":"bibr29-1358863X231199489","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207899"}],"container-title":["Vascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X231199489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1358863X231199489","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X231199489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:34:14Z","timestamp":1777692854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1358863X231199489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1177\/1358863X231199489"],"URL":"https:\/\/doi.org\/10.1177\/1358863x231199489","relation":{},"ISSN":["1358-863X","1477-0377"],"issn-type":[{"value":"1358-863X","type":"print"},{"value":"1477-0377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}